Related Experiment Video
Updated: Dec 25, 2025
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Multiplex Screening Assay for Identifying Cytotoxic CD8+ T Cell Epitopes
Chek Meng Poh1, Jian Zheng2, Rudragouda Channappanavar2
1School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Abstract:
The cytotoxicity of epitope-specific CD8+ T cells is usually measured indirectly through IFNγ production. Existing assays that directly measure this activity are limited mainly to measurements of up to two specificities in a single reaction. Here, we develop a multiplex cytotoxicity assay that allows direct, simultaneous measurement of up to 23 different specificities of CD8+ T cells in a single reaction. This can greatly reduce the amount of starting clinical materials for a systematic screening of CD8+ T cell epitopes. In addition, this greatly enhanced capacity enables the incorporation of irrelevant epitopes for determining the non-specific killing activity of CD8+ T cells, thereby allowing to measure the actual epitope-specific cytotoxicity activities. This technique is shown to be useful to study both human and mouse CD8+ T cells. Besides, our results from human PBMCs and three independent infectious animal models (MERS, influenza and malaria) further reveal that IFNγ expression by epitope-specific CD8+ T cells does not always correlate with their cell-killing potential, highlighting the need for using cytotoxicity assays in specific contexts (e.g., evaluating vaccine candidates). Overall, our approach opens up new possibilities for comprehensive analyses of CD8+ T cell cytotoxicity in a practical manner.
Insights
A new multiplex assay directly measures CD8+ T cell killing activity against 23 specificities simultaneously. This method improves accuracy by distinguishing specific from non-specific cell killing, crucial for vaccine development.
Area of Science:
- Immunology
- Cellular Biology
- Assay Development
Background:
- CD8+ T cell cytotoxicity is critical for adaptive immunity.
- Current methods for measuring T cell killing are often indirect (e.g., IFNγ production) or limited in scope.
- Existing direct assays can only measure a few T cell specificities per reaction.
Purpose of the Study:
- To develop a novel multiplex assay for direct, simultaneous measurement of CD8+ T cell cytotoxicity.
- To enable high-throughput screening of T cell epitopes and assessment of specific killing activity.
- To investigate the correlation between IFNγ production and actual cell-killing potential.
Main Methods:
- Development of a multiplex cytotoxicity assay capable of measuring up to 23 epitope specificities in a single reaction.
- Inclusion of irrelevant epitopes to differentiate specific from non-specific T cell killing.
- Application of the assay to human peripheral blood mononuclear cells (PBMCs) and samples from MERS, influenza, and malaria animal models.
Main Results:
- The assay allows direct, simultaneous measurement of up to 23 CD8+ T cell specificities.
- The method reduces the need for starting clinical materials for epitope screening.
- IFNγ production did not consistently correlate with CD8+ T cell killing potential in tested models.
- The assay demonstrated utility in both human and mouse CD8+ T cells.
Conclusions:
- The developed multiplex assay offers a practical and comprehensive approach for analyzing CD8+ T cell cytotoxicity.
- This technique is valuable for systematic screening of T cell epitopes and evaluating vaccine candidates.
- Direct measurement of cytotoxicity is essential, as IFNγ expression alone may not reflect cell-killing capacity.
